Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	99	39	34	23	26	-
Market Cap Growth	-6.07%	15.15%	46.04%	-12.70%	-	-
Enterprise Value	96	36	28	15	26	-
Last Close Price	0.55	0.30	-	-	-	-
PS Ratio	31.40	1810.77	102.74	33.37	-	-
PB Ratio	15.76	9.16	5.80	3.25	2.46	-
P/TBV Ratio	15.76	9.16	5.80	3.25	2.46	-
EV/Sales Ratio	29.37	1669.05	84.98	21.72	-	-
Debt / Equity Ratio	0.00	0.01	0.01	-	-	-
Asset Turnover	0.23	0.00	0.02	0.04	-	-
Inventory Turnover	6.68	6.43	-	-	-	-
Quick Ratio	6.58	0.88	12.49	20.29	12.32	1.47
Current Ratio	10.19	2.08	12.73	20.56	12.41	1.52
Return on Equity (ROE)	-5.42%	-125.11%	-59.86%	-33.45%	-94.88%	-
Return on Assets (ROA)	-1.02%	-23.19%	-14.94%	-10.76%	-19.18%	-
Return on Capital (ROIC)	-3.06%	-76.89%	-39.95%	-24.17%	-53.56%	-
Earnings Yield	-0.25%	-16.23%	-11.26%	-12.30%	-22.02%	-
FCF Yield	-1.96%	-11.65%	-9.98%	-13.12%	-14.97%	-
Buyback Yield / Dilution	-14.39%	-13.88%	-0.23%	6.29%	-105.51%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.